NCT00648986View on ClinicalTrials.gov

Efficacy and Safety Study of Tazarotene (Tazorac) for the Treatment of Brittle Nails

PHASE4CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions

Brittle Nails

Interventions

DRUG

Tazorac

All patients were to apply topical tazarotene (Tazorac) twice daily to all affected fingernails for 24 weeks.

Trial Locations (1)

10032

Columbia University Medical Center, New York

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Allergan

INDUSTRY

lead

Columbia University

OTHER